Further Testing for Easy Bruising with Normal Coagulation Studies
For a 29-year-old female with easy bruising and normal PTT, CBC, and INR, von Willebrand disease testing should be performed as the next step, including von Willebrand factor antigen (VWF:Ag), von Willebrand factor ristocetin cofactor activity (VWF:RCo), and factor VIII coagulant activity (FVIII). 1
Rationale for Testing
Normal coagulation studies (PTT, CBC, INR) do not exclude common bleeding disorders such as von Willebrand disease (VWD), which is:
- The most common inherited bleeding disorder
- Often presents with normal PT/PTT/INR
- More common in women due to hormonal influences and menstrual bleeding
Recommended Testing Algorithm
First-line specialized testing:
- Von Willebrand factor antigen (VWF:Ag)
- Von Willebrand factor ristocetin cofactor activity (VWF:RCo)
- Factor VIII coagulant activity (FVIII)
If initial VWD testing is normal, consider:
- Platelet function testing, including light transmission aggregometry with multiple agonists 1
- Testing for platelet granule release
- Flow cytometry for platelet surface glycoproteins
If high clinical suspicion persists despite normal testing:
Important Considerations
Patient factors affecting test results:
- Stress, exercise, inflammation, pregnancy, or estrogen use can elevate VWF and FVIII levels, potentially masking disorders 1
- ABO blood type influences VWF levels (Type O individuals have ~30% lower levels)
- Medications should be reviewed (discontinue those affecting platelet function 7-10 days before testing)
Classification insights:
- Easy bruising syndrome can be categorized into two types 3:
- Type I: Normal to supranormal platelet function
- Type II: Abnormal platelet function with impaired aggregation
- Easy bruising syndrome can be categorized into two types 3:
Limitations of screening tests:
When to Refer
- Refer to a hematologist when:
This approach ensures thorough evaluation of the most likely causes of easy bruising in a young woman with normal basic coagulation studies, with von Willebrand disease being the most important condition to rule out first.